Tamar Mordechai

Research Assistant
Splisense, Israel

Poster(s):

• (615) Antisense Oligonucleotide-Based Drug Development for Cystic Fibrosis Patients Carrying the 2789+5 G-to-A Splicing Mutation
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (620) Antisense Oligonucleotide Splicing Modulation as a Novel Cystic Fibrosis Therapeutic Approach for the N1303K Nonsense Mutation
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET